These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25017095)

  • 21. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment.
    Liu H; Li Y; Mozhi A; Zhang L; Liu Y; Xu X; Xing J; Liang X; Ma G; Yang J; Zhang X
    Biomaterials; 2014 Aug; 35(24):6519-33. PubMed ID: 24797882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H; Cevher E; Alpar HO
    Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles.
    Li W; Zhao H; Qian W; Li H; Zhang L; Ye Z; Zhang G; Xia M; Li J; Gao J; Li B; Kou G; Dai J; Wang H; Guo Y
    Biomaterials; 2012 Jul; 33(21):5349-62. PubMed ID: 22542611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of Doxorubicin Encapsulated PLGA Nanoparticles and Bcl-xL shRNA Using Alkyl-Modified PEI into Breast Cancer Cells.
    Ebrahimian M; Taghavi S; Mokhtarzadeh A; Ramezani M; Hashemi M
    Appl Biochem Biotechnol; 2017 Sep; 183(1):126-136. PubMed ID: 28236188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galactosylated chitosan-g-PEI/DNA complexes-loaded poly(organophosphazene) hydrogel as a hepatocyte targeting gene delivery system.
    Jiang HL; Kim YK; Lee SM; Park MR; Kim EM; Jin YM; Arote R; Jeong HJ; Song SC; Cho MH; Cho CS
    Arch Pharm Res; 2010 Apr; 33(4):551-6. PubMed ID: 20422364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
    Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
    Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
    Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
    Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy.
    Li T; Zhang M; Wang J; Wang T; Yao Y; Zhang X; Zhang C; Zhang N
    AAPS J; 2016 Jan; 18(1):146-55. PubMed ID: 26381779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.
    Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
    Biomaterials; 2012 Aug; 33(22):5574-83. PubMed ID: 22579235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
    Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
    J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
    Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
    Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells.
    Moffatt S; Cristiano RJ
    Int J Pharm; 2006 Jul; 317(1):10-3. PubMed ID: 16713147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer.
    Peng H; Yang H; Song L; Zhou Z; Sun J; Du Y; Lu K; Li T; Yin A; Xu J; Wei S
    J Exp Clin Cancer Res; 2016 Mar; 35():57. PubMed ID: 27029190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles.
    Kumar K; Vulugundam G; Jaiswal PK; Shyamlal BRK; Chaudhary S
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4288-4293. PubMed ID: 28838699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly(organophosphazene)-polyethylenimine conjugate hydrogels.
    Seo BB; Park MR; Chun C; Lee JY; Song SC
    Biomaterials; 2011 Nov; 32(32):8271-80. PubMed ID: 21839508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor efficacy of doxorubicin-loaded laponite/alginate hybrid hydrogels.
    Gonçalves M; Figueira P; Maciel D; Rodrigues J; Shi X; Tomás H; Li Y
    Macromol Biosci; 2014 Jan; 14(1):110-20. PubMed ID: 23966317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
    Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
    Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
    Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy.
    Gao S; Tian H; Guo Y; Li Y; Guo Z; Zhu X; Chen X
    Acta Biomater; 2015 Oct; 25():184-93. PubMed ID: 26169933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.